Jazz Pharmaceuticals (JAZZ) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | -0.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.95% |
| Dec 31, 2025 | -42.31% |
| Sep 30, 2025 | -40.22% |
| Jun 30, 2025 | -12.24% |
| Mar 31, 2025 | 29.00% |
| Dec 31, 2024 | 60.18% |
| Sep 30, 2024 | 66.07% |
| Jun 30, 2024 | 5.73% |
| Mar 31, 2024 | 23.59% |
| Dec 31, 2023 | 70.88% |
| Sep 30, 2023 | 59.13% |
| Jun 30, 2023 | 80.28% |
| Mar 31, 2023 | 137.94% |
| Dec 31, 2022 | 49.04% |
| Sep 30, 2022 | 24.95% |
| Jun 30, 2022 | -20.21% |
| Mar 31, 2022 | -76.60% |
| Dec 31, 2021 | -44.09% |
| Sep 30, 2021 | -9.46% |
| Jun 30, 2021 | 13.40% |
| Mar 31, 2021 | 198.96% |
| Dec 31, 2020 | 65.97% |
| Sep 30, 2020 | -6.69% |
| Jun 30, 2020 | 23.26% |
| Mar 31, 2020 | 28.15% |
| Dec 31, 2019 | 105.85% |
| Sep 30, 2019 | 59.35% |
| Jun 30, 2019 | 31.47% |
| Mar 31, 2019 | 20.81% |
| Dec 31, 2018 | -19.79% |
| Sep 30, 2018 | 97.54% |
| Jun 30, 2018 | 102.78% |
| Mar 31, 2018 | 30.60% |
| Dec 31, 2017 | 5.48% |
| Sep 30, 2017 | -31.09% |
| Jun 30, 2017 | -72.44% |
| Mar 31, 2017 | -64.58% |
| Dec 31, 2016 | -62.99% |
| Sep 30, 2016 | -63.30% |
| Jun 30, 2016 | -5.82% |
| Mar 31, 2016 | 25.20% |
| Dec 31, 2015 | 44.55% |
| Sep 30, 2015 | 73.70% |
| Jun 30, 2015 | 243.57% |
| Mar 31, 2015 | 218.29% |
| Dec 31, 2014 | 7.47% |
| Sep 30, 2014 | -2.28% |
| Jun 30, 2014 | -46.81% |
| Mar 31, 2014 | -45.42% |
| Dec 31, 2013 | 64.39% |
| Sep 30, 2013 | 210.05% |
| Jun 30, 2013 | 226.32% |
| Mar 31, 2013 | 163.99% |
| Dec 31, 2012 | 371.75% |
| Sep 30, 2012 | 87.51% |
| Jun 30, 2012 | 50.93% |
| Mar 31, 2012 | 162.30% |
| Dec 31, 2011 | 83.23% |
| Sep 30, 2011 | 342.90% |
| Jun 30, 2011 | 969.52% |